5,000 vol­un­teers sought for COVID-19 vac­cine tri­als in Chicago area: Here’s how to sign up

Chicago Sun-Times - - TOP NEWS - Sun-Times staff re­port

North­west­ern Medicine is seek­ing up to 5,000 peo­ple to take part in up­com­ing vac­cine stud­ies to pre­vent COVID-19 in­fec­tion.

The med­i­cal cen­ter said Mon­day it is sign­ing up those at high risk for ex­po­sure to the coro­n­avirus for a newly launched Preven­tion Tri­als Registry.

“We want to re­cruit par­tic­i­pants in the Chicago area who are at risk for ex­po­sure to COVID-19 and who are po­ten­tially in­ter­ested in par­tic­i­pat­ing in dif­fer­ent stud­ies for preven­tion of the in­fec­tion,” Dr. Karen Krueger, a North­west­ern Medicine physi­cian and in­struc­tor in in­fec­tious dis­eases at Fein­berg School of

Medicine, said in a writ­ten state­ment.

The first study is ex­pected to start next month. The Phase 3 trial will test the ef­fec­tive­ness of a vac­cine by As­traZeneca that was found safe and boosted an­ti­body re­sponses in Phase 1 and 2 tri­als, the state­ment said. The drug will be tested at North­west­ern’s Streeter­ville cam­pus and at Lake For­est and Cen­tral DuPage hos­pi­tals.

The registry is seek­ing adults who work in jobs that put them at higher risk for ex­po­sure, in­clud­ing in health care fa­cil­i­ties, gro­cery stores, re­tail, pub­lic trans­porta­tion or fac­to­ries. Those who work in nurs­ing homes or other “con­gre­gated liv­ing fa­cil­i­ties” are also be­ing sought.

North­west­ern also wants those “dis­pro­por­tion­ately af­fected by COVID-19” — such as peo­ple with health con­di­tions, se­niors, African Amer­i­cans, Lati­nos or Na­tive Amer­i­cans — to sign up.

“We are cast­ing a re­ally wide net so we can make sure we have enough peo­ple iden­ti­fied and ready to go for up­com­ing stud­ies,” Krueger said.

For more de­tails, con­tact nu­vac­cines­tudy@north­west­ern.edu or call (312) 694-0414.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.